In development: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Expected publication date

Expected publication date

Guidance programme

HealthTech approach

HealthTech approach

Advice programme

Area of interest

Showing 381 to 388 of 388

TitleTypeExpected publication date
Xanomeline tartrate–trospium chloride for treating schizophrenia ID6716Technology appraisal guidanceTBC
Zanidatamab with chemotherapy with or without tislelizumab for untreated HER2-positive unresectable advanced gastro-oesophageal adenocarcinoma ID6672Technology appraisal guidanceTBC
Zanubrutinib for untreated chronic lymphocytic leukaemia [ID5079]Technology appraisal guidanceTBC
Zilucoplan for treating antibody positive generalised myasthenia gravis [ID4008]Technology appraisal guidance
Zio XT for detecting cardiac arrhythmiasMedical technologies guidanceTBC
Zolbetuximab with nab-paclitaxel and gemcitabine for untreated claudin 18.2-positive metastatic pancreatic cancer [ID6444]Technology appraisal guidanceTBC
Zongertinib for treating HER2-mutated unresectable or metastatic non-small-cell lung cancer ID6573Technology appraisal guidanceTBC
Zuranolone for treating postnatal depression [ID6431]Technology appraisal guidanceTBC

Results per page

  1. 10
  2. 25
  3. 50
  4. All